Quince Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Quince Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Quince Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -38.8 %, a 25.6% decline year-over-year.
  • Quince Therapeutics, Inc. annual Return On Assets for 2023 was -28.8 %, a 37.5% increase from 2022.
  • Quince Therapeutics, Inc. annual Return On Assets for 2022 was -46.2 %, a 20.9% increase from 2021.
  • Quince Therapeutics, Inc. annual Return On Assets for 2021 was -58.4 %, a 60.3% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -38.8 -7.9 -25.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -24.2 +15.6 +39.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -28.8 +17.3 +37.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -30.2 +28.1 +48.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -30.9 +33.8 +52.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -39.8 +23.6 +37.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.2 +12.2 +20.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -58.3 -6.52 -12.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -64.8 -17.1 -36% Apr 1, 2022 Jun 30, 2022
Q1 2022 -63.4 -21.4 -51% Jan 1, 2022 Mar 31, 2022
Q4 2021 -58.4 -22 -60.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -51.8 -16.5 -46.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -47.6 -15.4 -47.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -42 -11.4 -37% Jan 1, 2021 Mar 31, 2021
Q4 2020 -36.4 -5.03 -16% Oct 1, 2020 Dec 31, 2020
Q3 2020 -35.2 -8.52 -31.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -32.2 Apr 1, 2020 Jun 30, 2020
Q1 2020 -30.7 Jan 1, 2020 Mar 31, 2020
Q4 2019 -31.4 Oct 1, 2019 Dec 31, 2019
Q3 2019 -26.7 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.